Related Experiment Video

Updated: Jul 15, 2026

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays
08:39

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays

Published on: January 3, 2015

8.9K

Molecular markers for cervical cancer prognosis: a prognostic model using stemness-related lncRNAs and functional

Xiaochen Liu1,2,3, Yuandong Liao1,3, Yunyun Liu1,3

  • 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

BMC Cancer
|April 21, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
BioinformaticsCESCEMX2OSMolecular markersPrognostic modelStemness-related lncRNAs

More Related Videos

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

13.5K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

965

Related Experiment Videos

Last Updated: Jul 15, 2026

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays
08:39

Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays

Published on: January 3, 2015

8.9K
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

13.5K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

965

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...

Articles linked to this work by shared authors, journal, and citation graph.

Functional and transcriptomic characterization of the receptor-like protein kinase gene GmHSL1b involved in salt stress tolerance in soybean roots.

Physiologia plantarum·2025

A noncanonical role of SAT1 enables anchorage independence and peritoneal metastasis in ovarian cancer.

Nature communications·2025

Effect of Hypoglycemic Drugs on Patients with Heart Failure with or without T2DM: A Bayesian Network Meta-analysis.

Reviews in cardiovascular medicine·2025

Cuproptosis inhibits tumor progression and enhances cisplatin toxicity in ovarian cancer.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025

Accuracy of 3D CE-MRA combined with ultrasound microbubble angiography for the diagnosis of lower extremity atherosclerotic occlusion.

American journal of translational research·2025

Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer.

Signal transduction and targeted therapy·2025

Co-expression of non-signaling CARs enhances EGFRvIII-specific CAR T-cell cytotoxicity against head and neck squamous cell carcinoma.

BMC cancer·2026

Insights into the survival impact of delayed immunochemotherapy in newly diagnosed diffuse large B-cell lymphoma: results from a nationwide registry study.

BMC cancer·2026

Comparative effectiveness of neoadjuvant therapy combined with stent placement versus stent alone in obstructive colorectal cancer: a multicenter retrospective analysis.

BMC cancer·2026

The effect of adding ovarian function suppression to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer who have undergone neoadjuvant therapy: a single-center experience.

BMC cancer·2026

Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple myeloma - the BELI(E)VE trial.

BMC cancer·2026

Family-centred psycho-oncological counselling for parents with cancer: a longitudinal secondary data analysis of psychological distress, family functioning and parental concerns.

BMC cancer·2026

Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Gastrointestinal endoscopy·2026

Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Gastroenterology·2026

Semen quality in men with cancer: comparison with a healthy Swiss reference population.

Reproduction & fertility·2026

Early clinical outcomes, treatment adherence, and toxicity profile of adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: Real-world data from India.

Indian journal of cancer·2026

Gastric cancer in the young: A real-world experience.

Indian journal of cancer·2026

Correlation of perineural invasion and histopathological features/clinical outcomes for carcinoma oral cavity: An analysis of 781 patients.

Indian journal of cancer·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us